DIO3OS and myomatous neoplasm: These outcomes of the TCGA-SARC cohort indicated that the DIO3OS expression was an excellent diagnostic biomarker for distinguishing osteosarcoma from lipomatous neoplasms, myomatous neoplasms, nerve sheath tumors, and synovial-like neoplasms.